Loading...
SGLT2i: beyond the glucose-lowering effect
Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the clinical treatment of type 2 diabetes mellitus (T2DM)....
Saved in:
| Published in: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320582/ https://ncbi.nlm.nih.gov/pubmed/32590982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01071-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|